Recalls / Generics / Norgestimate And Ethinyl Estradiol
Norgestimate And Ethinyl Estradiol
3 FDA drug recalls involving generic “Norgestimate And Ethinyl Estradiol”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-09-02 | Class II | Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 | AvKARE |
| 2024-03-07 | Class II | Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton conta | Teva Pharmaceuticals USA, Inc |
| 2021-03-15 | Class II | TRI-LO-MARZIA 0.180MG/0.025MG; 0.215 MG/0.025MG AND 0.250MG/0.025MG 3X28 BPK; NDC/UPC 68180-837-73; RX; TABLE | Cardinal Health Inc. |